COLO B Coloplast A/S Class B

Coloplast A/S - Allocation of Share Options

Coloplast A/S - Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transactions concern allocation of share options.

For further details, reference is made to Coloplast’s Remuneration Policy. The policy is available on the group website at this address:







 Details of the person discharging managerial responsibilities/person closely associated
a)NameLars Rasmussen
2Reason for the notification
a)Position/statusInterim President & CEO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.00  33,897  
d)Aggregated information 
-        Aggregated volume33,897 share options
-        PriceDKK 0.00
e)Date of the transaction2026-03-10, 09:00 UTC
f)Place of the transactionOutside a trading venue
1Details of the person discharging managerial responsibilities/person closely associated
a)NameAnders Lonning-Skovgaard
2Reason for the notification
a)Position/statusExecutive Vice President & CFO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.00  43,134  
d)Aggregated information 
-        Aggregated volume43,134 share options
-        PriceDKK 0.00
e)Date of the transaction2026-03-10, 09:00 UTC
f)Place of the transactionOutside a trading venue

For further information, please contact

Investors and analysts

Anders Lonning-Skovgaard

Executive Vice President, CFO

Tel.

Kristine Husted Munk

Senior Director, Investor Relations

Tel. /

Email:

Simone Dyrby Helvind

Senior Manager, Investor Relations

Tel. /

Email:

Press and media

Peter Mønster

Head of Media Relations & Corporate Content

Tel.

Email:

Address

Coloplast A/S

Holtedam 1

DK-3050 Humlebaek

Denmark

Company reg. (CVR) no. 69749917

Website







This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.

The Coloplast story begins back in 1954. Elise Sørensen is a nurse. Her sister Thora has just had an ostomy operation and is afraid to go out in public, fearing that her stoma might leak. Listening to her sister’s problems, Elise conceives the idea of the world’s first adhesive ostomy bag. Based on Elise’s idea, Aage Louis-Hansen, a civil engineer and plastics manufacturer, and his wife Johanne Louis-Hansen, a trained nurse, created the ostomy bag. A bag that does not leak, giving Thora – and thousands of people like her – the chance to live the life they want.

A simple solution that makes a difference.

Today, the Coloplast Group develops products and services that help millions of people live more independent lives through solutions tailored to their needs. Globally, our business areas include Ostomy Care, Continence Care, Voice & Respiratory Care, Wound & Tissue Repair, and Interventional Urology.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2026-03.



All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Please see enclosed pdf.

Attachment



EN
10/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

Coloplast AS: 1 director

A director at Coloplast AS bought 4,362 shares at 458.590DKK and the significance rating of the trade was 85/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

ResearchPool Subscriptions

Get the most out of your insights

Get in touch